3/31/2023 Cost-effectiveness of second-line ipilimumab for metastatic melanoma: a real-world population-based cohort study of resource utilization Lu B, Dai WF, Croxford R, Isaranuwatchai W, Beca J, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Cancer Med. 2023; Mar 31 [Epub ahead of print]. DOI: https://doi.org/10.1002/cam4.5862
1/10/2023 Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in Canada Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Tinmouth J, Eskander A. JAMA Netw Open. 2023; 6(1):e2250394. Epub 2023 Jan 10. DOI: https://doi.org/10.1001/jamanetworkopen.2022.50394
11/1/2022 Incident cancer detection during multiple waves of COVID-19: the tsunami after the earthquake Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Gomez D, McIsaac DI, Enepekides D, Urbach DR, Eskander A. J Natl Compr Canc Netw. 2022; 20(11):1190-92. Epub 2022 Nov 1. DOI: https://doi.org/10.6004/jnccn.2022.7075
Global News4/7/2022Article New evidence suggests pandemic is having a lasting impact on cancer patients
The Conversation4/4/2022Article Cancer treatment and diagnosis backlogs during COVID-19 may affect cancer survival